Web Release Date: January 23,
Total Synthesis of the Ramoplanin A2 and Ramoplanose Aglycon
Contribution from the Department of Chemistry and the Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037
Received October 1, 2002

Abstract:
Full details of a convergent total synthesis of the ramoplanin A2 and ramoplanose aglycon are
disclosed. Three key subunits composed of residues 3-9 (heptapeptide 15), pentadepsipeptide 26 (residues
1, 2 and 15-17), and pentapeptide 34 (residues 10-14) were prepared, sequentially coupled, and cyclized
to provide the 49-membered depsipeptide core of the aglycon. Key to the preparation of the pentadepsipeptide 26 incorporating the backbone ester was the asymmetric synthesis of an orthogonally protected
L-threo-
-hydroxyasparagine and the development of effective and near-racemization free conditions for
esterification of its hindered alcohol (EDCI, DMAP, 0
C). The coupling sites were chosen to maximize the
convergency of the synthesis including that of the three subunits, to prevent late stage racemization of
carboxylate-activated phenylglycine-derived residues, and to enlist
-sheet preorganization of an acyclic
macrocyclization substrate for 49-membered ring closure. By altering the order of final couplings, two
macrocyclization sites, Phe9-D-Orn10 and Gly14-Leu15, were examined. Macrocyclization at the highly
successful Phe9-D-Orn10 site (89%) may benefit from both
-sheet preorganization as well as closure at
a D-amine terminus within the confines of a
-turn at the end of the H-bonded antiparallel
-strands. A
more modest, but acceptable macrocyclization reaction at the Gly14-Leu15 site (40-50%) found at the
other end of the H-bonded antiparallel
-strands within a small flexible loop may also benefit from
preorganization of the cyclization substrate, is conducted on a substrate incapable of competitive
racemization, and accommodates the convergent preparation of analogues bearing depsipeptide modifications. Deliberate late-stage incorporation of the subunit bearing the labile depsipeptide ester and a final
stage Asn1 side-chain introduction provides future access to analogues of the aglycons which themselves
are equally potent or more potent than the natural products in antimicrobial assays.
Download the full text: PDF | HTML